Speakers of African parliaments backed Morocco's vaccine manufacturing plans and praised its pandemic assistance to African states. Morocco's health authorities describe production capacity as a project under development, not established serial output.
The appeal was issued after a consultation meeting in Rabat on Thursday. Speakers of African parliaments called for greater health sovereignty across the continent in an "Appeal for vaccines and medicines for all in Africa."
The support is clear. But the appeal described a project launch, not vaccine production already underway. On September 30, 2026, Morocco's Ministry of Health reported preparations for an industrial unit to produce sera, vaccines and biological products. The ministry presented it as a project being launched, not an operating source of serial production, in its official project update.
Moroccan parliamentary speakers praised efforts led by HM King Mohammed VI to establish vaccine production in Morocco. They cited the launch of a project to manufacture and mobilize anti-Covid-19 vaccines and other vaccines. They also credited the King with supervising its implementation and concluding agreements connected to it. The appeal said these steps would make the Kingdom a continental production platform serving African people. It gave no production figures or timetable.
The Ministry of Health describes vaccine sovereignty as a phased industrial strategy. The first step is a biotechnology and vaccine plant. A plant to produce pharmaceutical active ingredients would follow. The ministry has also recorded the opening of a quality-control laboratory for vaccines and biotechnology products at the Centre for Sera and Vaccines. Testing matters.
The Ministry of Health identifies the Institut Pasteur du Maroc as responsible for supplying vaccines, sera and biological products. It still describes the institute as operating pending implementation of a project to establish production units through a public-private partnership. That status separates the strategic goal from production at scale.
The initiative adds an industrial dimension to Morocco's wider economic positioning, a topic covered in Maghreb Insider's investment climate coverage. The Ministry of Health also reported that four memorandums of understanding were signed on July 23, 2024, to strengthen domestic production of medicines and medical products. The effort reaches beyond vaccines.
The speakers also praised measures ordered by HM King Mohammed VI during the first months of the pandemic. Morocco sent emergency medical assistance to several African countries. The supplies included drugs, masks, respirators and sterilizers, intended to strengthen those countries' response capacity. The appeal linked the deliveries to an initiative launched by the King and other African heads of state in the first weeks of the outbreak. Its goal was to coordinate and unify the continent's response.
Morocco's early pandemic campaign also relied on imported vaccines. The Ministry of Health's historical record notes the arrival of the country's first COVID-19 vaccine shipment and a separate emergency authorization for Sinopharm. That history shows the supply challenge the later production plans seek to address. A project announcement is not enough.
The speakers warned that the pandemic's health and socio-economic effects were hitting African people and economies. Many countries, they said, faced limited medical infrastructure and weak capacity in medicines and vaccines.
The appeal gives Morocco political backing for a role in continental vaccine production. It does not show that output has begun. African health sovereignty will depend on whether the announced effort becomes a functioning, quality-controlled source of vaccines and medicines for the continent.
